NEOADJUVANT TREATMENT
Clinical trials for NEOADJUVANT TREATMENT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT TREATMENT trials appear
Sign up with your email to follow new studies for NEOADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug zanzalintinib aims to shrink thyroid tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests the drug zanzalintinib given before surgery in 45 people with advanced thyroid cancer. The goal is to see if the drug can shrink tumors, making surgery more effective. Researchers will also monitor safety and side effects.
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Promising cocktail aims to shrink esophageal tumors before surgery
Disease control Recruiting nowThis study tests whether combining the immunotherapy adbelimumab with chemotherapy and the targeted drug apatinib can help shrink esophageal tumors before surgery. About 35 adults with resectable esophageal squamous cell carcinoma will receive four cycles of the drug combo, then …
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Feeding tube before cancer surgery may cut risks
Knowledge-focused Recruiting nowThis study looks at whether giving extra nutrition through a feeding tube before surgery can lower the chance of complications in malnourished people with esophageal or stomach cancer. About 670 participants will be followed to compare those who get nutritional support with those…
Matched conditions: NEOADJUVANT TREATMENT
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC